ReviewiScience2025
Review on fiber composites for sustainable high strain rate applications.
Review in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past two decades, the growing demand for sustainable, high-performance materials has driven significant advancements in fiber reinforced polymer composites (FRPCs), particularly for dynamic and ballistic applications. This review provides an integrated overview of recent developments, highlighting sustainable reinforcements, novel stacking configurations, and advanced machine learning (ML) predictive approaches. Particular emphasis is placed on bio-inspired helicoidal laminates and hybrid architectures, which offer superior energy absorption, damage tolerance, and impact mitigation. Hybrid laminates incorporating satin weaves, high-modulus fibers, and compliant matrices enhance post-impact toughness and better structural integrity. Additionally, embedding a high-hardness (70-90 Shore A) rubber core with a compliant matrix mitigates conical crack propagation, improves strain rate sensitivity, and reduces delamination under both low- and high-velocity impacts. The dynamic response of FRPCs is examined using experimental techniques such as Split Hopkinson Pressure Bar (SHPB) testing and impact assessments, revealing the influence of design variables on strain-rate-dependent behavior. To support material selection and design optimization in fiber composites, ML techniques, Ashby charts, and Multi-Criteria Decision-Making (MCDM) frameworks are explored, balancing performance, sustainability, and manufacturability. Failure mechanisms such as delamination, fiber pull-out, and matrix cracking are analyzed with respect to hybridization strategies and environmental effects. Finite element analysis (FEA) tools, including ABAQUS, ANSYS AUTODYN, and LS-DYNA, are reviewed for their predictive accuracy, validated against experimental results. Standardized testing protocols (ASTM D7136, D7137, F1342; NIJ-0101.06) ensure the consistent evaluation of both flexible and rigid armor systems. The review also discusses manufacturing advancements such as resin transfer molding (RTM) and filament winding, which improve scalability and reduce waste. Non-destructive testing (NDT) methods, including acoustic emission, ultrasonic C-scanning, and X-ray CT, are highlighted for real-time damage assessment. Finally, integrating ML algorithms such as MLP, SVM, RF, and CNN with experimental and simulation data enhances predictive modeling, damage classification, and tailored composite design. This convergence of bio-inspired design, computational tools, and intelligent systems is accelerating the development of next-generation FRPCs for aerospace, defense, automotive, and civil engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.